Yu XM - Search Results

1

Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.

Yu XM, Lo CY, Lam AK, Leung P, Luk JM. Yu XM, et al. Ann Surg. 2008 Mar;247(3):483-9. doi: 10.1097/SLA.0b013e31815fa447. Ann Surg. 2008. PMID: 18376194

2

Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.

Yu XM, Lo CY, Chan WF, Lam KY, Leung P, Luk JM. Yu XM, et al. Clin Cancer Res. 2005 Nov 15;11(22):8063-9. doi: 10.1158/1078-0432.CCR-05-0646. Clin Cancer Res. 2005. PMID: 16299237

3

The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma.

Yu XM, Lo CY, Lam AK, Lang BH, Leung P, Luk JM. Yu XM, et al. Surgery. 2008 Dec;144(6):934-40; discussion 940-1. doi: 10.1016/j.surg.2008.07.027. Surgery. 2008. PMID: 19041000

4

Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases.

Yu XM, Wan Y, Sippel RS, Chen H. Yu XM, et al. Ann Surg. 2011 Oct;254(4):653-60. doi: 10.1097/SLA.0b013e318230036d. Ann Surg. 2011. PMID: 21876434

5

Current treatment of papillary thyroid microcarcinoma.

Yu XM, Lloyd R, Chen H. Yu XM, et al. Adv Surg. 2012;46:191-203. doi: 10.1016/j.yasu.2012.03.002. Adv Surg. 2012. PMID: 22873040 Review.

6

Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases.

Yu XM, Schneider DF, Leverson G, Chen H, Sippel RS. Yu XM, et al. Thyroid. 2013 Oct;23(10):1263-8. doi: 10.1089/thy.2012.0453. Epub 2013 Sep 11. Thyroid. 2013. PMID: 23477346 Free PMC article.

7

Notch3 as a novel therapeutic target in metastatic medullary thyroid cancer.

Lou I, Odorico S, Yu XM, Harrison A, Jaskula-Sztul R, Chen H. Lou I, et al. Among authors: yu xm. Surgery. 2018 Jan;163(1):104-111. doi: 10.1016/j.surg.2017.07.039. Epub 2017 Nov 8. Surgery. 2018. PMID: 29128180 Free PMC article.

8

False-negative fine-needle aspiration of thyroid nodules cannot be attributed to sampling error alone.

Yu XM, Patel PN, Chen H, Sippel RS. Yu XM, et al. Am J Surg. 2012 Mar;203(3):331-4; discussion 334. doi: 10.1016/j.amjsurg.2011.09.016. Epub 2012 Jan 28. Am J Surg. 2012. PMID: 22284047

9

The Epstein-Barr virus EBNA2 protein induces a subset of NOTCH target genes in thyroid cancer cell lines but fails to suppress proliferation.

Golden S, Yu XM, Odorico S, Jain V, Marin A, Ma S, Kenney S, Chen H. Golden S, et al. Among authors: yu xm. Surgery. 2017 Jan;161(1):195-201. doi: 10.1016/j.surg.2016.06.068. Epub 2016 Nov 12. Surgery. 2017. PMID: 27847111 Free PMC article.

10

Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo.

Yu XM, Phan T, Patel PN, Jaskula-Sztul R, Chen H. Yu XM, et al. Cancer. 2013 Feb 15;119(4):774-81. doi: 10.1002/cncr.27742. Epub 2012 Sep 18. Cancer. 2013. PMID: 22991264 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

321 results

Search Page

Filters